{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:36:48Z","timestamp":1785368208338,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jneuroim.2020.577397","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:16:52Z","timestamp":1600427812000},"page":"577397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Modulation of immune responses by bile acid receptor agonists in myasthenia gravis"],"prefix":"10.1016","volume":"349","author":[{"given":"Quentin","family":"Howlett-Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourosh","family":"Rezania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Soliven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577397_bb0005","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI110668","article-title":"Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum","volume":"70","author":"Angelin","year":"1982","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","author":"Aricha","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0015","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1084\/jem.20170580","article-title":"B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity","volume":"214","author":"Arkatkar","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11306-019-1625-z","article-title":"Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis","volume":"16","author":"Blackmore","year":"2020","journal-title":"Metabolomics."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0035","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-gamma, and GM-CSF and diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11255-014-0901-0","article-title":"Mechanism underlying an elevated serum bile acid level in chronic renal failure patients","volume":"47","author":"Chu","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0045","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-alpha","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0896-8411(03)00044-1","article-title":"The complex role of interleukin-10 in autoimmunity","volume":"20","author":"Groux","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 Inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0070","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1189\/jlb.0812396","article-title":"Bile acids PKA-dependently induce a switch of the IL-10\/IL-12 ratio and reduce proinflammatory capability of human macrophages","volume":"94","author":"Haselow","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0075","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1073\/pnas.1524890113","article-title":"Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis","volume":"113","author":"Ho","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0080","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1021\/jm501052c","article-title":"G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype","volume":"57","author":"Hogenauer","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0085","doi-asserted-by":"crossref","first-page":"106130","DOI":"10.1016\/j.intimp.2019.106130","article-title":"Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis","volume":"80","author":"Hu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-016-1593-6","article-title":"The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion","volume":"132","author":"Hucke","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2567.2012.03554.x","article-title":"Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway","volume":"136","author":"Ichikawa","year":"2012","journal-title":"Immunology."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fneur.2017.00043","article-title":"Regulatory B cells in seropositive myasthenia gravis versus healthy controls","volume":"8","author":"Karim","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0105","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100883","article-title":"A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo","volume":"9","author":"Lewis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577397_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1749-8546-7-6","article-title":"Metabolomic profiles of myocardial ischemia under treatment with salvianolic acid B","volume":"7","author":"Lu","year":"2012","journal-title":"Chin. Med."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2013.09.014","article-title":"Altered expression of miR-146a in myasthenia gravis","volume":"555","author":"Lu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2009.10.040","article-title":"Clinical implications of the type 1\/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients","volume":"627","author":"Masuda","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0135","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1038\/s41598-018-32700-y","article-title":"Fecal microbiota profile in a group of myasthenia gravis patients","volume":"8","author":"Moris","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2013.00129","article-title":"Regulation of adaptive immunity; the role of interleukin-10","volume":"4","author":"Ng","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0145","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/jm049904b","article-title":"Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid","volume":"47","author":"Pellicciari","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0150","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered gut microbiota in myasthenia gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141082","article-title":"Reversal of endothelial dysfunction by GPBAR1 Agonism in portal hypertension involves a AKT\/FOXOA1 dependent regulation of H2S generation and Endothelin-1","volume":"10","author":"Renga","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577397_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2016.05.004","article-title":"Impaired regulatory B cells in myasthenia gravis","volume":"297","author":"Sheng","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0170","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0175","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mus.23951","article-title":"Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis","volume":"49","author":"Sun","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2020.577397_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/\u2212) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0185","doi-asserted-by":"crossref","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0195","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.50.4.1045","article-title":"T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis","volume":"50","author":"Wang","year":"1998","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0200","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10753-012-9526-6","article-title":"Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis","volume":"36","author":"Wang","year":"2013","journal-title":"Inflammation."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of myasthenia gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fneur.2017.00034","article-title":"B10 cell frequencies and suppressive capacity in myasthenia gravis are associated with disease severity","volume":"8","author":"Yi","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0220","doi-asserted-by":"crossref","first-page":"113146","DOI":"10.1016\/j.expneurol.2019.113146","article-title":"Inhibition of the transcription factor ROR-gamma reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis","volume":"325","author":"Yi","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08916934.2014.992517","article-title":"B cells produce less IL-10, IL-6 and TNF-alpha in myasthenia gravis","volume":"48","author":"Yilmaz","year":"2015","journal-title":"Autoimmunity."},{"key":"10.1016\/j.jneuroim.2020.577397_bb0230","doi-asserted-by":"crossref","first-page":"1901441","DOI":"10.1002\/advs.201901441","article-title":"Perturbed microbial ecology in myasthenia gravis: evidence from the gut microbiome and fecal metabolome","volume":"6","author":"Zheng","year":"2019","journal-title":"Adv. Sci. (Weinh)."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820304938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820304938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:37:02Z","timestamp":1759048622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820304938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"alternative-id":["S0165572820304938"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577397","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of immune responses by bile acid receptor agonists in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577397"}}